CRNDE has been reported to promote the proliferation, migration, and invasion of glioma through attenuating miR-384/PIWIL4/STAT3 axis (23) and facilitating EGFR activation to modulate glioma growth (24). This evidence concerns the gene EGFR and central nervous system cancer.